BlueWillow Biologics Awarded Grant for Chlamydia Vaccine Development
October 2, 2018
BlueWillow Biologics Awarded Grant for Chlamydia Vaccine Development – 9/26/2018 BlueWillow Biologics® has been awarded a NIH Small Business Innovation Research (SBIR) grant for the development of an intranasal NanoVax® vaccine for the prevention of chlamydia. There are more than 131 million new chlamydia infections worldwide each year and no approved vaccine currently exists to […]